Synonym: 4-(4-Benzofurazanyl)-1,-4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid methyl 1-methylethyl ester
CAS Number: 75695-93-1
Empirical Formula (Hill Notation): C19H21N3O5
Molecular Weight: 371.39
MDL Number: MFCD00153820
Linear Formula: C19H21N3O5
Product Type: Chemical
| assay |
≥98% (HPLC) |
| color |
yellow |
| description |
Store under nitrogen |
| form |
solid |
| InChI |
1S/C19H21N3O5/c1-9(2)26-19(24)15-11(4)20-10(3)14(18(23)25-5)16(15)12-7-6-8-13-17(12)22-27-21-13/h6-9,16,20H,1-5H3 |
| InChI key |
HMJIYCCIJYRONP-UHFFFAOYSA-N |
| originator |
Novartis |
| Quality Level |
100  |
| SMILES string |
COC(=O)C1=C(C)NC(C)=C(C1c2cccc3nonc23)C(=O)OC(C)C |
| solubility |
DMSO: >10 mg/mL |
| storage temp. |
2-8°C |
| Application: |
Isradipine has been used to explore neuroprotective activity. |
| Biochem/physiol Actions: |
Isradipine is considered as an active calcium channel blocker, used to treat hypertension. |
| Biochem/physiol Actions: |
L-type calcium channel blocker (also referred to as dihydropyridine-type calcium channel blocker); antihypertensive. |
| Biochem/physiol Actions: |
L-type calcium channel blocker; antihypertensive. |
| Features and Benefits: |
This compound was developed by Novartis . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: |
5, 25 mg in glass bottle |
| RIDADR |
NONH for all modes of transport |
| WGK Germany |
WGK 3 |
| Flash Point(F) |
Not applicable |
| Flash Point(C) |
Not applicable |
| Purity |
≥98% (HPLC) |
| Storage Temp. |
2-8°C |
| UNSPSC |
12352200 |
